Overview

A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers

Status:
Completed
Trial end date:
2020-05-22
Target enrollment:
Participant gender:
Summary
A clinical study to measure the Safety, Tolerability, and Pharmacokinetics of OP-101 After Subcutaneous Administration in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Orpheris, Inc.
Treatments:
Acetylcysteine
N-monoacetylcystine